Go back to Community Assays
JAK2 V617F
The JAK2 V617F mutation is a well-characterized biomarker commonly studied in blood cancer research, such as myeloproliferative neoplasms.
The JAK2 V617F mutation is a well-characterized biomarker commonly studied in blood cancer research, such as myeloproliferative neoplasms.